WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
Early detection, diagnosis, and treatment of newborn diseases are critically important. Timely newborn screening can prevent death and improve patient care outcomes. CLSI newborn screening laboratory standards provide test collection instructions, as well as information on methods for the detection of metabolic and hereditary disorders. Browse our newborn screening products below.
CLSI NBS10 describes a newborn screening system for detecting congenital hypothyroidism (CH). It discusses both first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as screening strategies for identifying newborns at increased risk for CH.
This guideline describes the basic principles, scope, and range of follow-up and education activities within the newborn screening program and system.
This guideline discusses the detection of X-linked. adrenoleukodystrophy by population-based newborn screening using dried blood spot specimens to measure C26:0-lysophosphatidylcholine.
